Skip to main content
SpringerLink
Log in

Transmural myocardial infarction. Focus on current strategies of myocardial reperfusion

  • Conference paper
Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E.

  • 183 Accesses

Abstract

Although acute myocardial infarction (AMI) continues to be a major health problem with significant rates of morbidity and mortality [1], substantial improvements in the management of the disease have been achieved over the last decades, which in turn have lead to better outcomes of the patients [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Hearth Association (1999) Heart and stroke facts: 1999 Statistical Supplement. American Hearth Association, Dallas, pp 1–36

    Google Scholar 

  2. Tunstall-Pedoe H, Mahonen M, Tolonen H, et al for the WHO MONICA (monitoring trends and determinants in cardiovascular disease) Project (1999) Contribution of trends in survival and coronary-event rates to changes in coronary hearth disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet 353:1547–1557

    Article  PubMed  CAS  Google Scholar 

  3. Falk E, Shah PK, Fuster V (1995) Coronary plaque disruption. Circulation 92:657–671

    Article  PubMed  CAS  Google Scholar 

  4. Fibrinolytic Therapy Trialists (FIT) Collaborative Group (1994) Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from aU randomized trials of more than 1000 patients. Lancet 343:311–322

    Google Scholar 

  5. Weaver WD, Simes RJ, Betriu A et al for the Primary Coronary Angioplasty versus Tlirombolysis Collaboration Group (1997) Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative overview. JAMA 278:2093–2098

    Google Scholar 

  6. Braunwald E (1998) Evolution of the management of acute myocardial infarction: a 20th century saga. Lancet 352:1771–1774

    Article  PubMed  CAS  Google Scholar 

  7. DeWood MA, Spores J, Notske R et al (1980) Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 303:897–902

    Article  PubMed  CAS  Google Scholar 

  8. Dorado DG, Theroux P, Elizaga J et al (1987) Myocardial infarction in the pig hearth model: infarct size and duration of coronary occlusion. Cardiovasc Res 21:537–544

    Article  Google Scholar 

  9. Flameng W, Lesaffre E, Vanhaecke J (1990) Determinants of infarct size in non-human primates. Basic Res Cardiol 85:392–403

    Article  PubMed  CAS  Google Scholar 

  10. Reimer KA, Vander Heide RS, Richard VJ (1993) Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models. Am J Cardiol 72:13G-21G

    Article  PubMed  CAS  Google Scholar 

  11. Califf RM, Bengtson JR (1994) Cardiogenic shock. N Engl J Med 330:1724–1730

    Article  PubMed  CAS  Google Scholar 

  12. Hataway WR, Peterson ED, Wagner GS et al for the GUSTO-I Investigators (1998) Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. JAMA 279:387–391

    Google Scholar 

  13. Gruppo Italiano per lo Studio della Streptochinasi nellTnfarto miocardico (GISSI) (1987) Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet 11:871–874

    Google Scholar 

  14. Mauri F, Franzosi MG, Maggioni AP et al (2002) Clinical value of 12-lead electrocardiography to predict the long-term prognosis of GISSI-1 patients. J Arn-Coll Cardiol 39; 1594–600

    Article  Google Scholar 

  15. Pfeffer MA, Braunwald E (1990) Ventricular remodeling after myocardial infarction, experimental observations and clinical implications. Circulation 81:1161–1172

    Article  PubMed  CAS  Google Scholar 

  16. St John Sutton M, Pfeffer MA, Plappert T et al for the SAVE investigators (1994) Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction, the protective effect of Captopril. Circulation 89:68–75

    Article  PubMed  CAS  Google Scholar 

  17. Kober L, Torp-Pedersen C, for the TRACE study group (1995) Clinical characteristics and mortality of patients screened for entry into the Trandolapril Cardiac Evaluation (TRACE) study. Am J Cardiol 76:1–5

    Article  PubMed  CAS  Google Scholar 

  18. Migrino RQ, Young JB, ElHs SG et al for the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators (1997) End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. Circulation 96: 116–121

    Google Scholar 

  19. Gruppo Italiano per lo Studio della Streptochinasi nellTnfarto miocardico (GISSI) (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1:397–402

    Google Scholar 

  20. The GUSTO Investigators (1993) An intemational randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329:673–682

    Article  Google Scholar 

  21. The Global Use of Strategies To Open Occluded Coronary Arteries (GUSTO-III) Investigators (1997) A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 337:1118–1123

    Article  Google Scholar 

  22. ASSENT-2 Investigators (1999) Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomized trial. Lancet 354:716–722

    Google Scholar 

  23. Califf RM, White HD, Van de Werf F (1996) One-year results from the Global Utilization of Streptokinase and TPA for Occluded coronary arteries (GUSTO-I) trial. Circulation 94: 1233–1238

    Article  PubMed  CAS  Google Scholar 

  24. Boersma E, Maas ACP, Deckers JW et al (1996) Eariy thrombolytic treatment in acute myocardial infarction: re-appraisal of the golden hour. Lancet 348:771–775

    Article  PubMed  CAS  Google Scholar 

  25. Simes RJ, Topol EJ, Holmes DR Jr for the GUSTO-I Investigators (1995) Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion: importance of early and complete infarct artery reperfusion. Circulation 91:1923–1928

    Article  PubMed  CAS  Google Scholar 

  26. Ross AM, Coyne KS, Moreya E et al (1998) The extended mortality benefit of early postinfarction reperfusion. Circulation 97:1549–1555

    Article  PubMed  CAS  Google Scholar 

  27. Lenderink T, Simoons ML, Van Es GA et al (1995) Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. Circulation 92:1110–1116

    Article  PubMed  CAS  Google Scholar 

  28. Reiner JS, Lundergan CF, Fung A et al (1996) Evolution of eariy TIMI 2 flow after thrombolysis for acute myocardial infarction. Circulation 94:2441–2446

    Article  PubMed  CAS  Google Scholar 

  29. Ohman EM, Califf RM, Topol EJ et al (1990) Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI study group. Circulation 82:781–791

    Article  PubMed  CAS  Google Scholar 

  30. Brouwer MA, Bihncke JR, Veen G et al (1995) Adverse long-term effects of reocclusion after coronary thrombolysis. J Am Coll Cardiol 26:1440–1444

    Google Scholar 

  31. GUSTO Angiographic Investigators (1993) The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 329:1615–1622

    Article  Google Scholar 

  32. LATE Study Group (1993) LATE Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6–24 hours after onset of acute myocardial infarction. Lancet 342:759–766

    Article  Google Scholar 

  33. 3. EMERAS (Estudio Multicentrico Estreptoquinasa Repúblicas de America del Sur) Collaborative Group (1993) Randomized trial of late thrombolysis in acute myocardial infarction. Lancet 342:767–772

    Article  Google Scholar 

  34. Wong C-K, French JK, Andrews J et al (2002) Usefulness of the presenting electrocardiogram in predicting myocardial salvage with thrombolytic therapy in patients with a first acute myocardial infarction. Eur Heart J 23:399–405

    Article  PubMed  Google Scholar 

  35. Puma J A, Sketch MH Jr, Thompson TD et al (1999) Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapy. Am J Cardiol 83:482–487

    Article  PubMed  CAS  Google Scholar 

  36. Kim CB, Braunwald E (1993) Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis. Circulation 88:2426–2436

    Google Scholar 

  37. Braunwald E (1989) Myocardial reperfusion, limitation on infarct size, reduction of left ventricular dysfunction and improved survival. Should the paradigm be expanded? Circulation 79:441–444

    Article  PubMed  CAS  Google Scholar 

  38. Hochman JS, Choo H (1987) Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 75:299–306

    Article  PubMed  CAS  Google Scholar 

  39. Sager PT, Perlmutter RA, Rosenfeld LE et al (1988) Electrophysiologic effects of thrombolytic therapy in patients with a transmural anterior myocardial infarction complicated by left ventricular aneurysm formation. J Am Coll Cardiol 12:19–24

    Article  PubMed  CAS  Google Scholar 

  40. Gang ES, Lew AS, Hong M et al (1989) Decreased incidence of ventricular late potentials after successful thrombolytic therapy for acute myocardial infarction. N Engl J Med 321:712–716

    Article  PubMed  CAS  Google Scholar 

  41. Lavie CJ, O’Keefe JH Jr, Chesebro JH et al (1990) Prevention of late ventricular dilatation after acute myocardial infarction by successful thrombolytic reperfusion. Am J Cardiol 66:31–36

    Article  PubMed  CAS  Google Scholar 

  42. Chesebro JH, Knatterud G, Roberts R et al (1987) Trombolysis In Myocardial Infarction (TIMI) Trial. Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 76:142–154

    Google Scholar 

  43. Ito H, Okamura A, Iwakura K et al (1996) Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 93:1993–1999

    Article  PubMed  CAS  Google Scholar 

  44. Kawamoto T, Yoshida K, Akasada T et al (1999) Can coronary blood flow velocity pattern after primary percutaneous transluminal coronary angiography predict recovery of regional left ventricular function in patients with acute myocardial infarction? Circulation 100:339–345

    Article  PubMed  CAS  Google Scholar 

  45. Maes A, Van de Werf F, Nuyts J et al (1995) Impaired myocardial tissue perfusion early after successful thrombolysis. Impact on myocardial flow, metabolism and function at late follow-up. Circulation 92:2072–2078

    Google Scholar 

  46. Wu KC, Zerhouni EA, Judd RM et al (1998) Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97:765–772

    Article  PubMed  CAS  Google Scholar 

  47. Beider MA de (2001) Acute myocardial infarction: failed thrombolysis. Heart 85:104–112

    Article  Google Scholar 

  48. Lemos JA de, Antman EM, Giugliano RP et al for the TIMI 14 Investigators (2000) ST segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Am J Cardiol 85:299–304

    Google Scholar 

  49. Fu Y, Goodman S, Chang WC et al (2001) Time to treatment influences the impact of ST-segment resolution on one-year prognosis. Insights from the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Trial. Circulation 104:2653–2659

    Article  PubMed  CAS  Google Scholar 

  50. White HD, French JK, Hamer AW et al (1995) Frequent reocclusion of patient infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy. J Am Coll Cardiol 25:218–223

    Article  PubMed  CAS  Google Scholar 

  51. Lincoff AM, Topol EJ (1993) Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation 88:1361–1374

    Article  PubMed  CAS  Google Scholar 

  52. Rezkalla SH, Kloner RA (2002) No-reflow phenomenon. Circulation 105:656–662

    Article  PubMed  Google Scholar 

  53. Granger CB, White HD, Bates ER et al (1994) A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction. Am J Cardiol 74:1220–1228

    Article  PubMed  CAS  Google Scholar 

  54. Lange RA, Hillis LD, Grines CL (1996) Should thrombolysis or primary angioplasty be the treatment of choice for acute myocardial infarction? N Engl J Med 335:1311–1317

    Article  PubMed  CAS  Google Scholar 

  55. Grines CL, Browne KF, Marco J et al for the Primary Angioplasty in Myocardial Infarction Study Group (1993) A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 328:673–679

    Google Scholar 

  56. Zijlstra F, Boer MJ de, Hoomtje JCA et al (1993) A comparison of immediate angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 328:680–684

    Article  PubMed  CAS  Google Scholar 

  57. Gibbons RJ, Holmes DR, Reeder GS et al for the Mayo Coronary Care Unit and Catheterization(1993) Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 328:685–691

    Google Scholar 

  58. Zijlstra F, Patel A, Jones M et al (2002) Clinical characteristics and outcome of patients with early (h), intermediate (2–4 h) and late (4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J 23:550–557

    Article  PubMed  CAS  Google Scholar 

  59. Antman EM, Braunwald E (2001) Acute myocardial infarction. In: Braunwald E, Zipes DP, Libby P (ed) Heart disease. A textbook of cardiovascular medicine 6th edn. Saunders, Philadelphia, pp 1114–1231

    Google Scholar 

  60. Califf RM, Topol EJ, Stack RS et al for the TAMI Study Group (1991) Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction-5 phase randomized trial. TAMI Study Group. Circulation 83:1543–1556

    Google Scholar 

  61. Ellis SG, Silva ER da, Heyndrickx GR et al for the RESCUE Investigators (1994) Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation 90:2280–2284

    Google Scholar 

  62. Vermeer F, Oude Ophuis AJM, Berg EJ vd et al (1999) Prospective randomized comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to hospital without PTCA faciüties: a safety and feasibility study. Heart 82:426–431

    PubMed  CAS  Google Scholar 

  63. Ellis SG, Silva ER da, Spaulding CM et al (2000) Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences. Am Heart J 139:1046–1053

    Google Scholar 

  64. Grech ED, Sutton AGC, Campbell PG et al (2000) Reappraising the role of immediate intervention following thrombolytic recanalization in acute myocardial infarction. Am J Cardiol 86:400–405

    Article  PubMed  CAS  Google Scholar 

  65. Topol EJ, Califf RM, George BS et al (1987) A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 317:581–588

    Article  PubMed  CAS  Google Scholar 

  66. Simoons ML, Arnold AE, Betriu A et al (1988) Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet 1:197–203

    Article  PubMed  CAS  Google Scholar 

  67. TIMI Study Group (1989) Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial. N Engl J Med 320:618–627

    Article  Google Scholar 

  68. Kleiman NS, Ohman EM, Califf RM et al (1993) Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 pilot study. J Am Coll Cardiol 22:381–389

    Article  PubMed  CAS  Google Scholar 

  69. The PARADIGM Investigators (1998) Combining thrombolysis with the platelet glycoprotein Ilb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction. J Am Coll Cardiol 32:2003–2010

    Article  Google Scholar 

  70. Ohman EM, Kleiman NS, Gocioch G et al for the IMPACT-AMI Investigators (1997) Combined accelerated tissue-plasminogen activator and platelet glycoprotein Ilb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-con- trolled, dose-ranging trial. Circulation 95:846–854

    Google Scholar 

  71. Antman EM, Giugliano RP, Gibson GM et al for the TIMI-14 Investigators (1999) Abciximab facilitates the rate and extent of thrombolysis. Results of the Thrombolysis In Myocardial Infarction (TIMI) 14 trial. Circulation 99:2720–2732

    Google Scholar 

  72. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group (2000) Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Circulation 101:2988–2994

    Google Scholar 

  73. Lefkovits J, Ivanhoe RG, Califf RM et al for the EPIC Investigators (1996) Effects of platelet glycoprotein Ilb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 77:1045–1051

    Google Scholar 

  74. Brener S J, Barr LA, Burchenal JEB et al on behalf of the ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators (1998) Randomized, placebo-controlled trial of platelet glycoprotein Ilb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation 98:734–741

    Google Scholar 

  75. Montalscot G, Barragan P, Wittenberg O et al (1999) Abciximab associated with primary angioplasty and stenting in acute myocardial infarction: the ADMIRAL study, 30 day final results (abstract). Circulation 100 [Suppl I]: 1–87

    Google Scholar 

  76. Miller JM, Smalling R, Ohman EM et al for the GUSTO-ffl Investigators (1999) Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Am J Cardiol 84:779–784

    Google Scholar 

  77. ACC/AHA Practice Guidelines (1999) 1999 update: ACC/AHA Guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations. Circulation 100:1016–1030

    Google Scholar 

Download references

Authors
  1. G. Sinagra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Sabbadini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Perkan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Perioperative Medicine, Intensive Care and Emergency, Trieste University School of Medicine, Trieste, Italy

    Antonino Gullo M.D. (Head) (Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Italia

About this paper

Cite this paper

Sinagra, G., Sabbadini, G., Perkan, A. (2003). Transmural myocardial infarction. Focus on current strategies of myocardial reperfusion. In: Gullo, A. (eds) Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E.. Springer, Milano. https://doi.org/10.1007/978-88-470-2215-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2215-7_9

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0194-7

  • Online ISBN: 978-88-470-2215-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation